Category Medicine and Healthcare
Press Release
Dr. Ran Rubinstein Expands Regenerative Treatment Options With Ariessence Pure PDGF+ in Montvale, NJ
Ariessence Pure PDGF+ is now available at Rubinstein Plastic Surgery Center, offering topical and injectable applications to support post-procedure healing, early skin aging, and hair restoration. Read More
Press Release
MIRA Pharmaceuticals Reports New Topical Ketamir-2 shows comparable effects to Injected Morphine in Preclinical Pain Study
Topical Ketamir-2 significantly reduced both acute and inflammatory pain behaviors in animals, demonstrating rapid onset, durable effect, and comparable efficacy to injected morphine across both pain phases Read More
Press Release
DEA's Marijuana Hypocrisy Laid Bare: As Rescheduling Looms, Agency's Ethical Failures and Research Obstruction Spark Outrage
Terrance Cole's First Test as Administrator MMJ BioPharma Cultivation's case exposes DEA's Diversion Control Division as a cartel of obstructionists who have abandoned science, betrayed public trust, and refused to follow the law. New DEA Administrator Terrance Cole inherited a mess. But now he has a chance to do something Judge Mulrooney, Thomas Prevoznik, Matthew Straitand Aarathi Haig never would: Tell the truth. Follow the law. And approve MMJ's long-blocked registration so clinical trials can finally begin. Read More
Press Release
Sia/LBG Receives Supplemental Grant to Expand Features for Global Health Cost Model Platform
Sia/LBG has been awarded a supplemental grant by the Gates Foundation to enhance its web-based cost and environmental impact modeling resource for pharmaceutical APIs Cost of Goods (COGs). Read More
Press Release
The Randstad Ride Event Benefits the NCCS to Empower Childhood Cancer Survivors Through the Beyond the Cure Ambassador Scholarship Program
This year's ride will raise critical funds to support the NCCS' Beyond the Cure Ambassador Scholarship Program, which empowers childhood cancer survivors to achieve their academic and professional dreams. Read More
Press Release
eXoZymes Details Biomanufacturing Breakthrough: 4 Grams of NCT with Over 99% Purity
Using eXoZymes' AI-driven exozymes platform, NCTx has demonstrated lab scale validation with 4 grams of NCT produced at a 96% yield and with a purity higher than 99%. NCT project went from concept to gram scale production in 5 months and at a fraction of normal SynBio R&D cost. N-trans-caffeoyltyramine (NCT) is a natural product compound attracting considerable interest from researchers and drug developers for its potential role in healthy liver fat metabolism, gut barrier function, and mitochondrial activity. Early access partners under material transfer agreement can sample the product and eXoZymes and NCTx is actively looking to increase the number of partners. Read More
Press Release
MIRA Pharmaceuticals Announces FDA Clearance of IND for Ketamir-2, Enabling U.S. Clinical Trials in Neuropathic Pain
Oral, non-opioid drug candidate advancing through Phase 1 and nearing completion of the single ascending dose (SAD) portion as the Company prepares to launch U.S. Phase 2a by year-end Read More
Press Release
CBD Life Sciences Inc. (CBDL) Nears Final Lease Agreement for Second High-Traffic Retail Location in Premier Arizona Mall, Signaling Major Expansion Phase
U.S. CBD market projected to exceed $36 billion by 2032 as foot traffic rebounds in top-tier malls with over 122 million monthly U.S. shoppers - CBDL strategically positioned at the intersection of both trends Read More
Press Release
Is DEA Marijuana Lies Civil Misconduct or Criminal Fraud? DEA Administrator's First Marijuana Decision
DEA Counsel's Conduct: Is It Fraud on the Tribunal? DEA attorney Aarathi D. Haig submitted a formal legal response on July 25, 2025 to DEA Administrator Terry Cole, asserting that MMJ BioPharma Cultivation lacked a bona fide supply agreement (BFSA) - the critical requirement for Schedule I bulk manufacturing registration. But this is provably false. That misrepresentation - made knowingly and in writing to the DEA Administrator and under the guise of the law - raises serious civil and criminal red flags. Read More
Press Release
Biolog Enters the European Diagnostic Market, Bringing 45 Years of Anaerobic Culture Excellence
Biolog, a leading provider of microbial identification and phenotypic characterization tools and services, announced today that both its anaerobic media and anaerobic chambers have received CE marking, clearing the way for broader international use Read More
Press Release
GEN and Sulfateq BV Announce Positive Phase 1 Trial Data on Investigational Drug SUL-238 for Alzheimer’s and Other Neurodegenerative Diseases
Phase 1 results demonstrate that SUL-238, a first-in-class, orally administered, mitochondria-directed drug candidate, is safe and well-tolerated in healthy elderly volunteers, showing a favourable pharmacokinetic profile and high brain penetration. These findings support the advancement of SUL-238 into further clinical development for Alzheimer's and other neurodegenerative diseases. Read More
Press Release
Neurocare Expands Clinic Network in the Netherlands With Acquisition of Perinatal Mental Health Specialists, MeJa Psychologie
This acquisition expands neurocare’s clinic network to 11 locations in the Netherlands and marks a key step into care focused on pregnancy, early parenthood, and family wellbeing. Read More
Press Release
DEA Scrambles to Defend Marijuana Decision Amid Supreme Court Ruling, Legal Collapse And Public Outrage
"This Wasn't DEA Marijuana Regulation - It Was a DEA Illegal Ambush." ALL EYES ON TERRY COLE! MMJ BioPharma Cultivation CEO Duane Boise is calling out the DEA's desperate attempt to defend a marijuana Administrative Law Judge decision that never got a hearing, blocked marijuana scientific evidence, and defied Supreme Court precedent. "They're defending a hearing that never actually happened," said Duane Boise. "We followed every rule. They followed none." Read More
Press Release
EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's COVID-19 mRNA Vaccine Targeting the SARS-CoV-2 Variant LP.8.1
Moderna's updated COVID-19 mRNA vaccine will be available for the 2025-2026 vaccination season, pending a European Commission authorization decision Read More
Press Release
Clinicians Benchmark Real-World AI Performance in Clinical Workflows: Survey Evaluates Safety, Accuracy, and Automation Readiness
Physicians Assess AI Tools Against 12 Frontline KPIs; 8 Solutions Surpass Expectations in Diagnostic Alignment, Workflow Support, and Communication Quality Read More
Press Release
Telomir Pharmaceuticals Reports Telomir-1's Unique Profile Restores Mitochondrial Health While Improving Oxidative Stress Without Promoting Cell Proliferation in Diseased Human Cell Lines Highlighting Potential Relevance to Neurodegenerative Pathways in Alzheimer's and Parkinson's
This unique cellular activity may help restore energy balance and improve essential cell functions such as protein synthesis and membrane stability in diseases like Parkinson's ALS Alzheimer's and Progeria where mitochondrial failure and oxidative stress drive progression Read More
Press Release
DEA Marijuana Rescheduling Judge Mulrooney Retires Amid Constitutional Crisis and MMJ Marijuana Research Lawsuit
As the DEA's unconstitutional house of cards collapses, its top obstructionists are fleeing like rats from a sinking ship. Judge John "McLooney" Mulrooney, the DEA's clownish Administrative Law Judge who presided over sham marijuana hearings now deemed unconstitutional, is retiring August 1. Policy chief Matthew Strait has already retired. Thomas Prevoznik, is rumored to be next. And all eyes are now on Aarathi Haig, DEA's lead counsel. Who will be the next to jump ship? Read More
Press Release
CaringAI Launches Voice-Based Dementia Care Platform, Appoints Dr. Stephanie Ruth Young as Clinical Research Advisor
Startup Introduces AI-Powered Voice-Based Cognitive Screening and Care Planning Platform, Guided by Expert in Aging, Neuropsychology and Implementation Science Read More
Press Release
DEA's Marijuana Rescheduling Administrative Law Sham: Unaccountable Judges, Rigged Trials
Whether it involves the DEA's much-publicized marijuana rescheduling efforts or MMJ BioPharma's lawful pursuit of a federal registration to conduct FDA-authorized clinical trials, one immovable obstacle remains: the DEA's constitutionally defective administrative adjudication system. Presided over by Chief Administrative Law Judge John J. Mulrooney II, this internal tribunal-often referred to as a "kangaroo court"-violates foundational principles of due process and Article II of the U.S. Constitution. Read More
Press Release
eXoZymes Biomanufacturing Breakthrough: From Concept to Gram-Scale NCT in Only 5 Months
N-trans-caffeoyltyramine (NCT) is a natural bioactive compound attracting considerable interest from researchers for its potential role in healthy liver fat metabolism, gut barrier function, and mitochondrial activity. Using eXoZymes' AI-driven platform, a new and proprietary approach to biomanufacturing of NCT - with all the scale-up advantages of an exozyme biosolution - has been developed: Progressing from concept to lab scale validation with gram-scale production in only 5 months and at a fraction of normal SynBio R&D cost. NCTx was created as a spin-out company to commercialize the NCT technology and is now able to provide early access partners, under material transfer agreement with product samples. NCTx and eXoZymes are actively looking to increase the number of partners. Read More
Press Release
